SERPINB3 and neoplasm: The baseline characteristics of the study population at the time of surgery, including a comparison between patients with high tumor expression of SerpinB3/4 (2+/3+) and patients with low SerpinB3/4 (0/1+), detected with the immunohistochemistry of the TMA scores, are reported in Table 2.